Related Experiment Video
Updated: Aug 7, 2025

Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry
Published on: March 24, 2023
Distinct GSDMB protein isoforms and protease cleavage processes differentially control pyroptotic cell death and
Sara S Oltra1,2,3, Sara Colomo2,3, Laura Sin1,2,3
1Fundación MD Anderson Internacional, Madrid, Spain.
Abstract:
Gasdermin (GSDM)-mediated pyroptosis is functionally involved in multiple diseases, but Gasdermin-B (GSDMB) exhibit cell death-dependent and independent activities in several pathologies including cancer. When the GSDMB pore-forming N-terminal domain is released by Granzyme-A cleavage, it provokes cancer cell death, but uncleaved GSDMB promotes multiple pro-tumoral effects (invasion, metastasis, and drug resistance). To uncover the mechanisms of GSDMB pyroptosis, here we determined the GSDMB regions essential for cell death and described for the first time a differential role of the four translated GSDMB isoforms (GSDMB1-4, that differ in the alternative usage of exons 6-7) in this process. Accordingly, we here prove that exon 6 translation is essential for GSDMB mediated pyroptosis, and therefore, GSDMB isoforms lacking this exon (GSDMB1-2) cannot provoke cancer cell death. Consistently, in breast carcinomas the expression of GSDMB2, and not exon 6-containing variants (GSDMB3-4), associates with unfavourable clinical-pathological parameters. Mechanistically, we show that GSDMB N-terminal constructs containing exon-6 provoke cell membrane lysis and a concomitant mitochondrial damage. Moreover, we have identified specific residues within exon 6 and other regions of the N-terminal domain that are important for GSDMB-triggered cell death as well as for mitochondrial impairment. Additionally, we demonstrated that GSDMB cleavage by specific proteases (Granzyme-A, Neutrophil Elastase and caspases) have different effects on pyroptosis regulation. Thus, immunocyte-derived Granzyme-A can cleave all GSDMB isoforms, but in only those containing exon 6, this processing results in pyroptosis induction. By contrast, the cleavage of GSDMB isoforms by Neutrophil Elastase or caspases produces short N-terminal fragments with no cytotoxic activity, thus suggesting that these proteases act as inhibitory mechanisms of pyroptosis. Summarizing, our results have important implications for understanding the complex roles of GSDMB isoforms in cancer or other pathologies and for the future design of GSDMB-targeted therapies.
Insights
Gasdermin-B (GSDMB) isoforms lacking exon 6 do not induce pyroptosis, promoting cancer progression. Exon 6 is crucial for GSDMB-mediated cell death and mitochondrial damage, offering therapeutic targets.
Area of Science:
- Cellular Biology
- Molecular Oncology
- Immunology
Background:
- Gasdermin-B (GSDMB) plays a dual role in cancer, mediating cell death or promoting tumor progression.
- Understanding GSDMB's precise mechanisms in pyroptosis and its isoforms is critical for cancer therapy.
Purpose of the Study:
- To elucidate the regions of GSDMB essential for pyroptosis.
- To investigate the differential roles of GSDMB isoforms in cancer cell death.
- To identify mechanisms regulating GSDMB-mediated pyroptosis.
Main Methods:
- Analysis of GSDMB isoforms and their functional domains.
- Assessment of cell death induction and mitochondrial damage.
- Investigation of protease cleavage sites and their impact on pyroptosis.
Main Results:
- Exon 6 translation is essential for GSDMB-mediated pyroptosis and mitochondrial damage.
- GSDMB isoforms lacking exon 6 (GSDMB1-2) do not induce cell death and associate with poor prognosis in breast cancer.
- Granzyme-A cleavage of exon 6-containing GSDMB isoforms induces pyroptosis, while Neutrophil Elastase and caspases inhibit it.
Conclusions:
- Exon 6 is a key determinant of GSDMB's pro-pyroptotic activity.
- Differential protease cleavage regulates GSDMB's role in cancer.
- Targeting GSDMB isoforms presents a potential therapeutic strategy for cancer.
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Caspases
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

